CIK 0001817229 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Vor Biopharma Inc.
Sign in to watch- Ticker
- VOR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 811591163
- Phone
- 617-655-6580
- Business address
- 500 BOYLSTON STREET, SUITE 1350, BOSTON, MA, 02116
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-01-29 | Chakraborty Tirtha CHIEF SCIENTIFIC OFFICER | Grant or award | +53,750 | 187,702 | ||
| 2024-01-29 | Chakraborty Tirtha CHIEF SCIENTIFIC OFFICER | Grant or award · Employee Stock Option (right to buy) | +107,500 | 107,500 | ||
| 2024-01-29 | ANG ROBERT PRESIDENT AND CEO | Grant or award | +150,000 | 830,925 | ||
| 2024-01-29 | ANG ROBERT PRESIDENT AND CEO | Grant or award · Employee Stock Option (right to buy) | +470,000 | 470,000 | ||
| 2024-01-29 | Jorgensen Nathan D. CHIEF FINANCIAL OFFICER | Grant or award | +50,000 | 198,449 | ||
| 2024-01-29 | Jorgensen Nathan D. CHIEF FINANCIAL OFFICER | Grant or award · Employee Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2023-11-06 | Chakraborty Tirtha Chief Scientific Officer | Shares withheld for taxes | −876 | $1.82 | $2K | 133,952 |
| 2023-11-06 | ANG ROBERT President and CEO | Shares withheld for taxes | −2,361 | $1.82 | $4K | 680,925 |
| 2023-11-06 | Jorgensen Nathan D. Chief Financial Officer | Shares withheld for taxes | −834 | $1.82 | $2K | 145,647 |
| 2023-11-06 | Attar Eyal C. Chief Medical Officer | Shares withheld for taxes | −999 | $1.82 | $2K | 51,533 |
| 2023-09-01 | Jorgensen Nathan D. Chief Financial Officer | Shares withheld for taxes | −6,310 | $2.67 | $17K | 146,481 |
| 2023-09-01 | Chakraborty Tirtha Chief Scientific Officer | Shares withheld for taxes | −5,576 | $2.67 | $15K | 134,828 |
| 2023-09-01 | ANG ROBERT President and CEO | Shares withheld for taxes | −12,657 | $2.67 | $34K | 683,286 |
| 2023-08-07 | Chakraborty Tirtha Chief Scientific Officer | Shares withheld for taxes | −875 | $2.67 | $2K | 140,404 |
| 2023-08-07 | Jorgensen Nathan D. Chief Financial Officer | Shares withheld for taxes | −834 | $2.67 | $2K | 152,791 |
| 2023-08-07 | Attar Eyal C. Chief Medical Officer | Shares withheld for taxes | −999 | $2.67 | $3K | 52,532 |
| 2023-08-07 | ANG ROBERT President and CEO | Shares withheld for taxes | −2,361 | $2.67 | $6K | 695,943 |
| 2023-05-26 | Resnick Joshua Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2023-05-26 | Patterson Matthew R Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2023-05-26 | Lubner David Charles Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 |
Page 13 of 18 · 344 trades